IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

Gross Margin
IRLAB Therapeutics AB

-177.7%
Current
-408%
Average
48.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-177.7%
=
Gross Profit
-73.9m
/
Revenue
41.6m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
SE
IRLAB Therapeutics AB
STO:IRLAB A
653.5m SEK
-178%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-3%
US
Eli Lilly and Co
NYSE:LLY
788.1B USD
81%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK
85%
US
Johnson & Johnson
NYSE:JNJ
384.8B USD
69%
US
Merck & Co Inc
NYSE:MRK
259.4B USD
76%
CH
Roche Holding AG
SIX:ROG
213.6B CHF
73%
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP
82%
CH
Novartis AG
SIX:NOVN
183.5B CHF
75%
US
Pfizer Inc
NYSE:PFE
160.4B USD
71%
Country SE
Market Cap 653.5m SEK
Gross Margin
-178%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 788.1B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.4T DKK
Gross Margin
85%
Country US
Market Cap 384.8B USD
Gross Margin
69%
Country US
Market Cap 259.4B USD
Gross Margin
76%
Country CH
Market Cap 213.6B CHF
Gross Margin
73%
Country UK
Market Cap 171.2B GBP
Gross Margin
82%
Country CH
Market Cap 183.5B CHF
Gross Margin
75%
Country US
Market Cap 160.4B USD
Gross Margin
71%

Profitability Report

View the profitability report to see the full profitability analysis for IRLAB Therapeutics AB.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-177.7%
=
Gross Profit
-73.9m
/
Revenue
41.6m
What is the Gross Margin of IRLAB Therapeutics AB?

Based on IRLAB Therapeutics AB's most recent financial statements, the company has Gross Margin of -177.7%.